DY
Dyadic International, Inc.
DYAI · NASDAQ
$0.45 -0.37% (-$0.00)
1M -13.52%
Market Cap $16.6M
P/E Ratio -
Div. Yield -
ROE 2,918.10%
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
3/9Valuation
37 /100
Fair P/S 4.77x
P/FFO N/A
P/B N/A
Growth
0 /100
Declining Book val. growth 51.92%
Rev. growth 25.08%
FCF growth N/A
Profitability
11 /100
Weak Net margin 219.50%
Op. margin 213.59%
FCF margin 213.22%
Quality
7 /100
Poor ROE 2,918.10%
ROA 116.60%
Asset turnover 0.53x
Debt
36 /100
Moderate Int. coverage -17.20x
Current ratio 1.65x
Net debt/EBITDA N/A
Stability
42 /100
Moderate Rev. volatility 44.35%
EPS volatility 22.87%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o DYAI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Mark A. Emalfarb
Employees
5
Headquarters
Jupiter
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report